Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation

Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis

Elizabeth A. Slee, Colin Adrain, Séamus J. Martin · Journal of Biological Chemistry · 2001 · 1.1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Synergistic drug combinations tend to improve therapeutically relevant selectivity

Joseph Lehár, Andrew Krueger, William Avery et al. · Nature Biotechnology · 2009 · 957 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Philip A. Harris, Amogh Boloor, Mui Cheung et al. · Journal of Medicinal Chemistry · 2008 · 345 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Khyati N. Shah, Roma Bhatt, Julia Rotow et al. · Nature Medicine · 2018 · 286 citations · Full text

Medicine, Molecular Biology, Oncology +14

Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

Gonzalo Recondo, Magda Bahcall, Liam F. Spurr et al. · Clinical Cancer Research · 2020 · 219 citations

Medicine, Molecular Genetics, Oncology +17